title: Treatment strategies for menstrually related migraine.
abstract: Approximately 50% of migrainous women suffer from menstrually related migraine (MRM), a type of migraine in which the attacks occur at the same time as or near the menstrual flow. Attacks of MRM tend to be longer, more intense and disabling and sometimes less responsive to treatment than non-menstrual migraines. Similar to the management of non-menstrual migraine, the use of triptans and NSAIDs is the gold standard for MRM treatment. In this paper, the most important studies in the literature that report the effectiveness of triptans, of certain associated drugs and other analgesic agents are summarized. Preventive strategies that can be used if a prophylactic treatment is needed is also analyzed, with particular attention paid to the use of perimenstrual prophylaxis with triptans and/or NSAIDs. Moreover, considering the peculiar interaction between menstrual migraine and female sex hormones, brief mention is made to possible hormonal manipulations.
authors.affiliation: Women's Headache Center, Department of Gynecology & Obstetrics, University of Turin, Turin, Italy. gb.allais@tiscali.it
authors.forename: Gianni
authors.initials: G
authors.lastname: Allais
authors.forename: Ilaria
authors.initials: I
authors.lastname: Castagnoli Gabellari
authors.forename: Ornella
authors.initials: O
authors.lastname: Mana
authors.forename: Chiara
authors.initials: C
authors.lastname: Benedetto
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D038801:International Classification of Diseases; D008597:Menstrual Cycle / Q000502:physiology*; D008599:Menstruation Disturbances / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D020325:Migraine with Aura / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D012720:Severity of Illness Index; D016896:Treatment Outcome